Below is a consolidated, dependencyâ€‘aware, priorityâ€‘ordered Toâ€‘Do list containing every partially done or unfinished item from roadmap (all remaining work only). Highest impact / highest leverage items are first. Finished (âœ… fully done) subâ€‘steps are omitted unless they frame context.

Legend: P# = Priority rank (1 = do first) Phase = Original roadmap phase Status: % (if given) or tag (ğŸŸ§ in progress / â³ pending / blank = not started) Effort: S (â‰¤1 day), M (multiâ€‘day <2 weeks), L (multiâ€‘week), XL (multiâ€‘month) â€” rough estimate Type: F=Foundational, C=Clinical, R=Regulatory/Compliance, S=Scale/Infra, RnD=Research/Innovation, Gov=Governance/Safety

TOP EXECUTION SEQUENCE (Quick View)

Close Phase 1 foundation gaps (imports, core engine, training pipeline, documentation)
Lock down security & compliance early (HIPAA prep overlaps engineering)
Complete EHR connectivity + Decision Support Dashboard core features (enables pilots)
Formalize validation (model + clinical) & start regulatory pathway
Stand up safety & scalability (cloud, monitoring) before multi-site rollout
Execute pilots (clinical + multi-condition expansion) with feedback loops
Advanced memory remaining insight + specialty & visualization modules
Long-horizon R&D (multi-modal, predictive analytics, international, rare disease, quantum)
DETAILED PRIORITIZED TOâ€‘DO LIST

P1 Phase 1 (Import Path Migration â€“ 95%) Status: Near-done Effort: S Type: F
Remaining:

Finish updating any remaining deprecated training.* to files.training.* (repo-wide scan)
Run final automated migration script and verify zero deprecation warnings
Update all docs/examples & run a linter/enforcer to prevent regressions
P2 Phase 1 (Core Engine Stabilization â€“ 85%) Status: In progress Effort: M Type: F
Remaining:

Optimize latency to consistently <100ms (profile hotspots â†’ apply batching/caching/vectorization)
Improve memory handling for large datasets (streaming loaders + controlled batching)
Refine NN architecture (hyperparameter sweep + pruning/quantization plan)
Full integration test incl. monitoring hooks, alert rules, performance SLO verification
P3 Phase 1 (Training Pipeline Enhancement â€“ 60%) Status: In progress Effort: M-L Type: F
Remaining:

Optimize Alzheimerâ€™s data preprocessing (I/O parallelism, normalization consistency)
Finish model validation framework (unit + integration tests; define acceptance thresholds)
Implement automated cross-validation & metric aggregation (CI integration)
Document pipeline (data flows, versioning strategy, run examples)
P4 Phase 1 (Documentation Overhaul) Status: Not started Effort: M Type: Gov
Remaining:

Audit docs for stale paths & outdated workflows
Update for new imports + pipeline changes
Add deployment & usage scenario examples (clinical + dev)
Conduct final editorial review & publish (establish doc versioning)
P5 Phase 2 (HIPAA Compliance Implementation) Status: Not started Effort: L Type: R
Remaining:

Implement encryption in transit + at rest (incl. key rotation policy)
Role-based access controls + audit logging (tamper-evident)
Privacy Impact Assessment (map data flows, risk register)
Penetration test + remediation report; formal compliance documentation package
P6 Phase 2 (EHR Connectivity â€“ ğŸŸ§) Status: In progress Effort: M-L Type: C
Remaining:

Real-time data ingestion protocol validation (throughput, idempotency)
API security hardening (OAuth2/SMART on FHIR scopes, threat modeling)
Launch pilot hospital ingestion (synthetic â†’ staged real data), capture feedback
P7 Phase 2 (Clinical Decision Support Dashboard â€“ ğŸŸ§) Status: In progress Effort: M-L Type: C
Remaining:

Integrate real-time patient monitoring widgets (stream pipeline + UI updates)
Add risk stratification visualizations (calibration, grouping, thresholds)
Pilot workflow integration (shadow mode trials, clinician feedback loop)
P8 Phase 2 (Model & Clinical Validation Enablers) Combined thread
A. Multi-Condition Support Expansion (not started) Type: C Effort: L

Stroke detection/assessment algorithms (feature engineering + evaluation)
Mental health / neuro spectrum modeling expansion
Cross-condition interaction analysis validation
Clinical review & sign-off panel formation
B. Clinical Pilot Programs (not started) Type: C Effort: L-XL
Secure institutional partnerships (MOUs / data governance agreements)
Run 1000+ case validation (establish statistical power plan)
UX/workflow optimization post-pilot feedback
Finalize user experience for broader roll-out
P9 Phase 2 (FDA Regulatory Pathway Planning) Status: Not started Effort: L Type: R
Remaining:

Determine device/software classification & regulatory strategy memo
Prepare pre-submission (Q-sub) briefing package & schedule meeting
Compile clinical evidence dossier structure (gap analysis)
Develop Quality Management System (QMS) documentation skeleton (SOPs)
P10 Phase 3 (Scalable Cloud Architecture) Status: Not started Effort: L Type: S
Remaining:

Multi-region IaC scripts (infra modules + environment parity tests)
Auto-scaling (load, latency, memory triggers) + capacity test harness
Observability for 99.9% uptime (SLO/SLI definitions, error budget policy)
Disaster recovery (RPO/RTO tests, backup/restore drills)
P11 Phase 3 (Advanced AI Safety Monitoring) Status: Not started Effort: L Type: Gov/Safety
Remaining:

Real-time bias detection & correction pipeline
Adversarial/robustness defense measures (input sanitization, anomaly detection)
Decision confidence scoring integration (calibration curves)
Human oversight protocols (escalation matrix, override audit trail)
P12 Phase 3 (Multi-Hospital Network Launch) Status: Not started Effort: XL Type: C/S
Remaining:

Finalize â‰¥25 institutional agreements
Scale infra to 10k+ concurrent patient cases (load + failover tests)
Integrate with regional health networks (interface compliance)
Outcome tracking dashboards (KPIs, longitudinal metrics)
P13 Phase 3 (Specialty Clinical Modules) Status: Not started Effort: L Type: C
Remaining:

Pediatric neurology adaptation (age-specific norms)
Geriatric care specialization (polypharmacy, comorbid profiles)
Emergency department workflow integration (triage latency)
Telemedicine platform connectors (session context synchronization)
P14 Phase 3 (Advanced Memory Consolidation â€“ partial) Status: ğŸŸ§ Effort: M Type: F/C
Remaining:

Extract population health insights module (aggregate cohort analytics)
P15 Phase 3 (3D Brain Visualization Platform) Status: Not started Effort: L Type: RnD/UI
Remaining:

Neurological mapping tools (data model + spatial rendering)
Disease progression visualization timelines
Treatment impact simulation layer (scenario modeling)
Educational/training interaction modules
P16 Phase 4 (Multi-Modal AI Integration) Status: Not started Effort: XL Type: RnD
Remaining:

Imaging analysis integration (DICOM pipeline, model fusion)
Genetic data correlation (variant normalization, feature embedding)
Biomarker pattern recognition modules
Voice/speech cognitive assessment ingestion & inference
P17 Phase 4 (Predictive Healthcare Analytics) Status: Not started Effort: XL Type: RnD
Remaining:

Population-level disease trend forecasting models
Personalized prevention strategy algorithms (risk scoring)
Treatment response analytics (temporal modeling)
Resource allocation optimization engine
P18 Phase 4 (International Healthcare Systems) Status: Not started Effort: XL Type: C/R
Remaining:

Multi-language clinical UI + terminology localization
Regional clinical practice adaptation (guideline mapping)
Deployment programs for developing regions (offline/low-bandwidth modes)
Global health data collaboration network framework (governance agreements)
P19 Phase 4 (Rare Disease Research Extension) Status: Not started Effort: L-XL Type: RnD
Remaining:

Orphan disease detection algorithms (few-shot/transfer methods)
Cross-institution collaboration features (secure federated learning)
Patient advocacy partnership program
Precision medicine analytics integration (variant + phenotype linking)
P20 Phase 4 (Quantum-Enhanced Computing) Status: Not started Effort: XL (Exploratory) Type: RnD
Remaining:

Quantum ML prototype integration (hybrid workflow)
Molecular structure simulation pipeline
Advanced optimization algorithms (QAOA / variational circuits)
Performance benchmarking & ROI assessment
DEPENDENCY / SEQUENCING NOTES

Foundational First: P1â€“P4 remove tech debt and stabilize baseline before scaling performance & compliance steps rely on consistent architecture.
Security & Compliance Early: P5 + partial P6 security tasks prevent costly retrofits later.
Clinical Readiness: P6â€“P8 feed evidence required for P9 FDA pathway.
Reg + Safety Pre-Scale: P9 and P11 precede large-scale multi-hospital (P12).
Scale Before Breadth: P10 (infra) must precede multi-hospital & specialty expansions (P12â€“P13).
Insight Layer: Memory population insights (P14) can run in parallel with P10 once data pipelines stable.
Visualization & Modules: P15 after stable inference + memory layers for richer data sources.
Long-Horizon R&D: P16â€“P20 positioned to not block operational go-live.

SUGGESTED NEXT 4-WEEK EXECUTION SLICE (if you want a sprint plan)

Week 1:

Finish P1 (imports) & accelerate P2 latency profiling
Kick off P3 validation framework skeleton
Begin HIPAA encryption + key management (P5)
Week 2:

Complete P2 performance + memory improvements
Advance P3 cross-validation automation
EHR ingestion protocol tests (P6)
Draft doc audit checklist (P4)
Week 3:

Wrap P3 remaining tasks
Implement API security hardening (P6)
Start risk stratification charts (P7)
Begin HIPAA audit logging (P5)
Week 4:

Complete Documentation Overhaul (P4)
Pilot hospital ingestion test (P6)
Dashboard workflow integration tests (P7)
Draft regulatory classification memo (P9 start)
RISK HOTSPOTS TO WATCH

Latency & memory (P2) slipping delays clinical pilot timing.
Delayed HIPAA (P5) blocks real production data ingestion.
Validation framework (P3) needed before credible FDA evidence (P9).
Security & bias monitoring (P11) must exist before multi-institution scale (P12).
METRIC CHECKPOINTS (Define Now)

Core engine: p95 latency <100ms; memory peak <X GB per N records.
Training pipeline: Automated CV run time; reproducibility hash; model acceptance threshold (e.g., AUC â‰¥ X).
EHR ingestion: Throughput msgs/sec; error rate <0.1%; end-to-end latency <Y sec.
Compliance: Encryption coverage 100%; audit log completeness 100%; penetration test critical findings = 0.
Dashboard: User task completion time; clinician satisfaction score; interpretability clarity rating.
Safety: Bias drift delta thresholds; adversarial detection true positive rate; override frequency.
